OrthoPediatrics Launches Its Enabling Technologies Division
OrthoPediatrics Corp. (NASDAQ: KIDS), a prominent name in pediatric orthopedics, has made a noteworthy advancement by launching its Enabling Technologies division. This move not only reflects the company's dedication to addressing various needs in pediatric orthopedics but also extends its influence into the rapidly growing sectors of digital health and advanced technologies. Spearheaded by industry expert Kevin Unger, this new division is set to reshape OrthoPediatrics' operations, enhancing its core business while exploring fresh revenue opportunities.
Building on Established Innovations
The company has already cemented its position as an industry leader by distributing the 7D Flash™ Navigation System and partnering with 3D Side, S.A. to develop patient-specific cutting guides. These groundbreaking initiatives provide a strong foundation for the newly formed Enabling Technologies division. Now, OrthoPediatrics is gearing up to introduce two cutting-edge technology platforms that promise to set new benchmarks in the medical arena.
Introducing Playbook
The first of these platforms, Playbook, is designed to revolutionize surgical workflows and optimize outcomes. This innovative tool centers on improving surgical planning, enhancing collaboration among medical teams, and refining intraoperative workflows. By simplifying these processes, Playbook seeks to increase surgery success rates and enhance patient outcomes, signaling a transformative change in surgical efficiency.
Robotic Assistance in Surgery
Alongside Playbook, OrthoPediatrics is rolling out a robotic-assisted technology tailored specifically for cochlear implant surgeries. In collaboration with iotaMotion, Inc., this pioneering technology aims to ensure more precise and controlled insertion of electrode arrays during procedures. With its compatibility across various cochlear implant manufacturers, this system is designed to enhance its versatility and effectiveness for pediatric patients.
CEO’s Vision and Commitment
David Bailey, the CEO of OrthoPediatrics, shared his excitement about the launch of the Enabling Technologies division. He remarked, "We're thrilled to introduce this new division, which will significantly expand our ability to positively impact children's lives and provide meaningful long-term growth opportunities. This is an exciting step forward in our commitment to innovation and supporting kids. We believe these advancements will not only enhance pediatric care but also position us at the forefront of the pediatric digital health and enabling technologies sectors."
Upcoming Investor Day
To keep the momentum going, OrthoPediatrics will host an investor day at 10:30 am E.T. This event aims to provide insights into the company’s future strategies and growth directions. Attendees will also be able to join a live webcast, allowing stakeholders and potential investors to engage directly with the company’s vision.
About OrthoPediatrics Corp.
Established in 2006, OrthoPediatrics is dedicated exclusively to advancing pediatric orthopedics. With a product portfolio that comprises over 70 items across key categories such as trauma, deformity correction, scoliosis, and sports medicine, the company stands as a market leader. OrthoPediatrics serves not just the United States but also over 70 countries around the globe, with a continued focus on enhancing the lives of children dealing with orthopedic conditions.
Contact Information
If you have any inquiries, please reach out to:
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406
Frequently Asked Questions
What is the focus of OrthoPediatrics' new division?
The Enabling Technologies division aims to enhance pediatric healthcare through innovations in digital health and advanced technologies.
How will Playbook improve surgical outcomes?
Playbook is designed to streamline surgical workflows and enhance collaboration among medical professionals, which can lead to more precise surgeries and improved patient outcomes.
What unique feature does the robotic assistance for cochlear implants offer?
This technology enables controlled insertion of electrode arrays that can work seamlessly with any cochlear implant manufacturer, thereby enhancing control during surgery.
When will the investor day event take place?
The investor day is set for 10:30 am E.T., and it will also be available as a live webcast.
How long has OrthoPediatrics been operating?
OrthoPediatrics was founded in 2006 and has been focused exclusively on advancements in pediatric orthopedics since then.
